RxSight, Inc.

US$4.54As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:RXSTHealthcare
Country USA
PE (Fwd) •••
TSR 5Y CAGR (21.25%)
Div yield —
ROE (20.10%)
Medical Devices
Beta (5Y) 1.19
PE TTM —
TSR TTM (48.35%)
Mkt cap US$190.4M
ROIC (83.88%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$4.35
(4.12%)
46.93%
Sell 0|8|1|12|10
4Q25
1Q26
2Q26
3Q26
Earnings per share$
0.05
0.06
0.05
0.06
21.45%
11.22%
15.67%
10.27%
Revenue$M
23.53
24.20
23.99
24.24
17.60%
14.57%
12.54%
8.37%
Peers (US$190.4M)
Cap (US$)
PE
193.2M
64.62x
163.8M
—
187.2M
17.74x
Capital
TTM
5Y
10Y
Leveragex
0.266
0.264
0.181
EBIT/Intx
0.969
0.301
0.232
Own earn%
(6.38)
(91.86)
(97.30)
Sh yield%
20.13
22.32
21.94
Owners
Insiders/Inst%
0.29
69.29
Short interest%
0.79
SBC / revenue%
4.89
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
23–27
$1 testx
−0.1
Incr. ROIC%
9